Identification of a dysfunctional exon-skipping splice variant in GLUT9/ SLC2A9 causal for renal hypouricemia type 2

Front Genet. 2023 Jan 17:13:1048330. doi: 10.3389/fgene.2022.1048330. eCollection 2022.

Abstract

Renal hypouricemia (RHUC) is a pathological condition characterized by extremely low serum urate and overexcretion of urate in the kidney; this inheritable disorder is classified into type 1 and type 2 based on causative genes encoding physiologically-important urate transporters, URAT1 and GLUT9, respectively; however, research on RHUC type 2 is still behind type 1. We herein describe a typical familial case of RHUC type 2 found in a Slovak family with severe hypouricemia and hyperuricosuria. Via clinico-genetic analyses including whole exome sequencing and in vitro functional assays, we identified an intronic GLUT9 variant, c.1419+1G>A, as the causal mutation that could lead the expression of p.Gly431GlufsTer28, a functionally-null variant resulting from exon 11 skipping. The causal relationship was also confirmed in another unrelated Macedonian family with mild hypouricemia. Accordingly, non-coding regions should be also kept in mind during genetic diagnosis for hypouricemia. Our findings provide a better pathogenic understanding of RHUC and pathophysiological importance of GLUT9.

Keywords: RHUC; genetic disorder; renal urate handling; splicing variant; urate.

Grants and funding

The present study was supported by the JSPS KAKENHI Grant Numbers 19K16441 and 21H03350 (to YT); 18KK0247, 20H00568, and 22KK0152 (to TT) as well as grants from the Czech Republic Ministry of Health RVO 00023728 and RVO VFN64165 (to BS); this project has been also funded in part with federal funds from the National Cancer Institute, National Institutes of Health, under contract HHSN26120080001E and in part by the Intramural Research Program of the NIH, Frederick National Lab, Center for Cancer Research (to CW) and was also supported by the new faculty research fund of Ajou University School of Medicine (to SC). YT has received a research grant from “The Nakajima Foundation”; TT has received research grants from “Gout and uric acid foundation of Japan” and “The Nakatomi Foundation.”